AAV mediated delivery of a novel anti-BACE1 VHH reduces Abeta in an Alzheimer’s disease mouse model
Rincon, M.; Zhou, L.; Marneffe, C.; Voytyuk, I.; Wouters, Y.; Dewilde, M.; Duque, S. I.; Vincke, C.; Levites, Y.; Golde, T. E.; Muyldermans, S.; De Strooper, B.; Holt, M. G.
Show abstract
Single domain antibodies (VHH) are potentially disruptive therapeutics, with important biological value for treatment of several diseases, including neurological disorders. However, VHH have not been widely used in the central nervous system (CNS), as it is hard to reach therapeutic levels, both because of their restricted blood-brain-barrier penetration and their apparent rapid clearance from the parenchyma. Here, we propose a gene transfer strategy based on adeno-associated virus (AAV)-based vectors to deliver VHH directly into the CNS, ensuring continuous production at therapeutic levels. As a proof-of-concept, we explored the potential of AAV-delivered VHH to inhibit BACE1, a well-characterized target in Alzheimers disease. First, we generated a panel of VHHs targeting BACE1. One of them, VHH-B9, showed high selectivity for BACE1 and efficacy in lowering BACE1 activity in vitro. We then went on to demonstrate significant reductions in amyloid beta (A{beta}) levels after AAV-based delivery of VHH-B9 into the CNS of a mouse model of cerebral amyloidosis. These results constitute a novel therapeutic approach for neurodegenerative diseases, which is applicable to a range of CNS disease targets.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease 93%
- RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS mice 93%
- Inhibition of Tau seeding by targeting Tau nucleation core within neurons with a single domain antibody fragment 92%
Similar papers in this journal
Similar papers in this journal
- Amelioration of symptomatic Alzheimer's Disease after selective impairment of p75NTR function in adult forebrainexcitatory neurons 94%
- ZCCHC17 modulates neuronal RNA splicing and supports cognitive resilience in Alzheimer's disease 93%
- Genetic mapping of APP and amyloid-β biology modulation by trisomy 21 92%
Similar papers in this journal
- LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathies 93%
- Lowering mutant huntingtin by small molecules relieves Huntington's disease symptoms and progression 92%
- NOTCH3 active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.